EUVIMEDEUVIMED entdecken
Crossref

Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine

Kanika Bharthi, Rayyan Zuberi, Abdullah Al Maruf iD, Sarker M Shaheen, Ryden McCloud, Madison Heintz, Laina McAusland, Paul D Arnold, Chad A Bousman iD

Journal of Child and Adolescent Psychopharmacology · 2024

DOI: 10.1089/cap.2023.0039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2024. Verfasst von Kanika Bharthi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Calgary, Calgary, Canada. Hauptthemen laut MEDLINE: Fluoxetine, Major Depressive Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineMajor Depressive DisorderChildHumansAdolescentCytochrome P-450 CYP2D6Selective Serotonin Reuptake InhibitorsCytochrome P-450 Enzyme SystemGenetic VariationPatient Reported Outcome Measures

Stichwörter der Autor:innen

Prozaccytochrome P450pharmacogeneticsresponsetolerabilityyouth

Substanzen

FluoxetineCytochrome P-450 CYP2D6Selective Serotonin Reuptake InhibitorsCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Calgary, Calgary, Canada.
  • Department of Medical Genetics, University of Calgary, Calgary, Canada.
  • College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
  • The Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Department of Psychiatry, University of Calgary, Calgary, Canada.
  • Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.

ORCID-Profile: Abdullah Al Maruf, Chad A Bousman

Zitieren

APA

Bharthi, K., Zuberi, R., Maruf, A. A., Shaheen, S. M., McCloud, R., Heintz, M., McAusland, L., Arnold, P. D., & Bousman, C. A. (2024). Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2023.0039

Vancouver

Bharthi K, Zuberi R, Maruf AA, Shaheen SM, McCloud R, Heintz M, et al. Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine. Journal of Child and Adolescent Psychopharmacology. 2024. doi:10.1089/cap.2023.0039

BibTeX
@article{Bharthi2024,
  author = {Bharthi, Kanika and Zuberi, Rayyan and Maruf, Abdullah Al and Shaheen, Sarker M and McCloud, Ryden and Heintz, Madison and McAusland, Laina and Arnold, Paul D and Bousman, Chad A},
  title = {Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2024},
  doi = {10.1089/cap.2023.0039}
}
Kostenlos starten →